An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Quantum-Si Incorporated (NASDAQ: QSI), known as The Protein Sequencing Company™, will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, from January 9-12, 2023. The company's management is set to present on January 12 at 10:30 am PST, discussing recent advancements including the launch of their innovative Platinum™ instrument, which enables next-generation single-molecule protein sequencing. A live and archived webcast will be available on the Quantum-Si website for those unable to attend.
Positive
None.
Negative
None.
GUILFORD, Conn.--(BUSINESS WIRE)--
Dec. 22, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023.
Quantum-Si’s management will present on Thursday, January 12 at 10:30 am Pacific Standard Time. The discussions will cover recent company developments, including the recently-announced commercial availability of Quantum-Si’s groundbreaking Platinum™ instrument, which is the first system to enable next-generation, single-molecule protein sequencing.
A live and archived webcast of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.